|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/496 | |
| A61K 31/538 | |||
| A61P 11/00 |
| (11) | Patento numeris | 3551187 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17811550.7 |
| Europos patento paraiškos padavimo data | 2017-12-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-10-16 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2017/081691 |
| Data | 2017-12-06 |
| (87) | Numeris | WO 2018/108669 |
| Data | 2018-06-21 |
| (30) | Numeris | Data | Šalis |
| 16203359 | 2016-12-12 | EP |
| (72) |
WOLLIN, Stefan, DE
WEX, Eva, DE
HERRMANN, Franziska, DE
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (54) | NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL |
| NINTEDANIB FOR USE IN METHODS FOR THE TREATMENT OF INTERSTITIAL LUNG DISEASES BY COADMINISTRATION WITH OLODATEROL |